Ensysce Biosciences, Inc. (ENSC) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 11 transactions totaling $776.0K, demonstrating a bullish sentiment with $776.0K in net insider flow. The most recent transaction on Mar 2, 2023 involved a purchase of 90,287 shares valued at $44.2K.
No significant insider buying has been recorded for ENSC in the recent period.
No significant insider selling has been recorded for ENSC in the recent period.
Based on recent SEC filings, insider sentiment for ENSC is bullish with an Insider Alignment Score of 100/100 and a net flow of $776.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Ensysce Biosciences, Inc. (ENSC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading ENSC stock, having executed 11 transactions in the past 90 days. The most active insider is Bob G. Gower (Executive), who has made 5 transactions totaling $727.4K.
Get notified when executives and directors at ENSC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | G. Gower Bob | Executive | Purchase | 90,287 | $0.49 | $44.2K | |
| Mar 1, 2023 | G. Gower Bob | Executive | Purchase | 270,000 | $0.48 | $129.6K | |
| Feb 28, 2023 | G. Gower Bob | Executive | Purchase | 109,300 | $0.49 | $53.6K | |
| Dec 9, 2022 | G. Gower Bob | Executive | Purchase | 357,143 | $1.40 | $500.0K | Large |
| May 26, 2022 | Kirkpatrick Lynn | Executive | Purchase | 27,000 | $0.53 | $14.3K | |
| May 25, 2022 | Kirkpatrick Lynn | Executive | Purchase | 70,000 | $0.49 | $34.3K | |
| Jun 30, 2021 | Kirkpatrick Lynn | Executive | Award | 284,851 | $N/A | $0 | |
| Jun 30, 2021 | G. Gower Bob | Executive | Award | 7,919,026 | $N/A | $0 | |
| Jun 30, 2021 | H. Chang William | Executive | Award | 2,242,189 | $N/A | $0 | |
| Jun 30, 2021 | H. Chang William | Executive | Award | 353,451 | $N/A | $0 | |
| Jun 30, 2021 | Carl Humphrey David | Executive | Award | 50,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 6 | $776.0K | 100.0% |
Award(A) | 5 | $0 | 0.0% |
Insiders at Ensysce Biosciences, Inc. are accumulating shares at an accelerated pace. With 4 insiders making 11 transactions totaling $776.0K in purchases versus $0 in sales, the net buying activity of $776.0K signals strong executive confidence. Bob G. Gower (Executive) leads the buying activity with $727.4K in transactions across all time.